MedPath

Air Barrier System for the Reduction of Airborne Colony-forming Units During Total Shoulder Arthroplasty

Not Applicable
Conditions
Osteo Arthritis Shoulders
Interventions
Device: Control
Device: Air Barrier System
Registration Number
NCT03782675
Lead Sponsor
Nimbic Systems, LLC
Brief Summary

The objective of this study is to determine whether the Air Barrier System device reduces airborne colony-forming units (e.g., bacteria) present at a surgery site during total shoulder arthroplasty surgeries.

Detailed Description

The Air Barrier System (ABS) is a device that uses localized clean air flow to shield a surgery site from ambient airborne contamination. This study examines the hypothesis that the ABS can reduce the presence of airborne CFU and particles at the surgery site during total arthroplasty surgery.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
40
Inclusion Criteria
  • Candidate for total shoulder arthroplasty
Exclusion Criteria
  • Prior history of infection
  • Revision surgery
  • Screens positive for MRSA

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
ControlControlIn the control arm, the ABS device will be placed as usual on the patient, but the airflow will NOT be activated. Only the technician in the room will be aware whether the device the device is turned on or not.
Air Barrier SystemAir Barrier SystemIn the experimental (interventional) arm, the ABS device will be placed as usual on the patient, and the airflow will be activated. Only the technician in the room will be aware whether the device is turned on or not.
Primary Outcome Measures
NameTimeMethod
CFU countsFour months

Inter-arm comparison of CFU counts taken during both the Control arm and ABS arm

Particle countsFour months

Inter-arm comparison of particle counts taken during both the Control arm and ABS arm.

Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath